Govx stock forecast despite current macroeconomic pressure

Despite current macroeconomic pressure, the "govx stock forecast" benefits from strong cash reserves, reducing immediate liquidity concerns in the next 6 months. Moreover, in another report by Reuters on the same day there were reports of the US dollar gaining as another key inflation measure fell in line with the forecasts. The Fed is expected to cut rates by 25 basis points this month. Moving forward markets have forecasted 100 bps of cuts by the end of 2024. GeoVax Labs has a consensus price target of $8.50, representing about 1,365.8% upside from its current price of $0.58. The latest "govx stock forecast" shows short-term volatility, with shares trading around $0.75, down 3% intraday. Analysts expect a potential rebound if biotech sector momentum recovers, especially given upcoming FDA data announcements.